CD14 and systemic lupus erythematosus: Interestingly, lower percentages of CD14+PLT+ were observed when SLE patients were segregated according to treatment with or without mycophenolate (48.08 ± 15.32 treated patients; 62.31 ± 15.5 not-treated patients; p = 0.028).